TALKING POINTS: Independent Panel Approves Authorization of Pfizer’s COVID-19 Vaccine Expansion to Children Ages 12-15
A summary of talking points and FAQs addressing the approval of COVID-19 vaccines for children ages 12-15. It includes facts and talking points laying out why it's important for this age group to get vaccinated.
Resource Types: HTML/text
What We Like About This Resource
Source Organization(s)
Resources
RELATED RESOURCES
EVENTS